Organisational Impact of a Remote Patient Monitoring System for Heart Failure Management: The Experience of 29 Cardiology Departments in France

Int J Environ Res Public Health. 2023 Feb 28;20(5):4366. doi: 10.3390/ijerph20054366.

Abstract

Remote patient monitoring (RPM) for the management of patients with chronic heart failure (CHF) has been widely studied from clinical and health-economic points of view. In contrast, data on the organisational impact of this type of RPM are scarce. The objective of the present study of cardiology departments (CDs) in France was to describe the organisational impact of the Chronic Care ConnectTM (CCCTM) RPM system for CHF. An organisational impact map for health technology assessment was used to identify and define the criteria evaluated in the present survey, including the care process, equipment, infrastructure, training, skill transfers, and the stakeholders' abilities to implement the care process. In April 2021, an online questionnaire was sent to 31 French CDs that were using CCCTM for CHF management: 29 (94%) completed the questionnaire. The survey results showed that CDs progressively modified their organisational structures upon or shortly after the implementation of the RPM device. Twenty-four departments (83%) had created a dedicated team, sixteen (55%) had provided dedicated outpatient consultations for patients with an emergency alert, and twenty-five (86%) admitted patients directly (i.e., avoiding the need to attend the emergency department). The present survey is the first to have assessed the organisational impact of the implementation of the CCCTM RPM device for CHF management. The results highlighted the variety of organisational structures, which tended to structure with the use of the device.

Keywords: ambulatory; emergency department; health technology assessment; heart failure; organisational impact; remote patient monitoring.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiology*
  • Chronic Disease
  • Emergency Service, Hospital
  • France
  • Heart Failure*
  • Humans
  • Monitoring, Physiologic / methods

Grants and funding

This research was funded by Air Liquide Santé International (Bagneux, France).